NR5A2 and Crohn disease: Further, a reduced expression of both NR5A2 and steroidogenic enzymes as well as a reduced local glucocorticoid release have been demonstrated in experimental murine colitis and in biopsies from inflamed colonic mucosa of Crohn’s disease and UC patients [35], and in isolated colonic epithelial cells from UC patients [36].